EUVIMEDEUVIMED entdecken
Crossref

UCHL1 aggravates skin fibrosis through an IGF ‐1‐induced Akt/ mTOR / HIF ‐1α pathway in keloid

Chipeng Guo iD, Lizhu Liang iD, Jingbin Zheng iD, Yang Xie iD, Xiaonan Qiu iD, Guozhen Tan iD, Jingang Huang iD, Liangchun Wang iD

The FASEB Journal · 2023-07 · 37 (7)

DOI: 10.1096/fj.202300153rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 31.05.2023. Verfasst von Chipeng Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Keloid, Skin Diseases. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Keloid is a heterogeneous disease featured by the excessive production of extracellular matrix. It is a great challenge for both clinicians and patients regarding the exaggerated and uncontrolled outgrowth and the therapeutic resistance of the disease. In this study, we verified that UCHL1 was drastically upregulated in keloid fibroblasts. UCHL1 had no effects on cell proliferation and migration, but instead promoted collagen I and α‐SMA expression that was inhibited by silencing UCHL1 gene and by adding in LDN‐57444, a pharmacological inhibitor for UCHL1 activity as well. The pathological process was mediated by IGF‐1 promoted Akt/mTOR/HIF‐1α signaling pathway because inhibition of any of them could reduce the expression of collagen I and α‐SMA driven by UCHL1 in fibroblasts. Also, we found that UCHL1 expression in keloid fibroblasts was promoted by M2 macrophages via TGF‐β1. These findings extend our understanding of the pathogenesis of keloid and provide potential therapeutic targets for the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KeloidSkin DiseasesHumansCell ProliferationCells, CulturedCollagen Type IFibroblastsInsulin-Like Growth Factor IProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesUbiquitin ThiolesteraseHypoxia-Inducible Factor 1, alpha Subunit

Stichwörter der Autor:innen

deubiquitinating enzymesextracellular matrixfibroblastkeloidskin

Substanzen

Collagen Type IInsulin-Like Growth Factor IProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesUbiquitin ThiolesteraseMTOR protein, humanUCHL1 protein, humanIGF1 protein, humanHIF1A protein, humanHypoxia-Inducible Factor 1, alpha Subunit

Autor:innen und Institutionen

  • Department of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Department of Dermatology, the Third Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Guangzhou, China.

ORCID-Profile: Chipeng Guo, Lizhu Liang, Jingbin Zheng, Yang Xie, Xiaonan Qiu, Guozhen Tan, Jingang Huang, Liangchun Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Guo, C., Liang, L., Zheng, J., Xie, Y., Qiu, X., Tan, G., Huang, J., & Wang, L. (2023). UCHL1 aggravates skin fibrosis through an IGF ‐1‐induced Akt/ mTOR / HIF ‐1α pathway in keloid. The FASEB Journal, 37(7). https://doi.org/10.1096/fj.202300153rr

Vancouver

Guo C, Liang L, Zheng J, Xie Y, Qiu X, Tan G, et al. UCHL1 aggravates skin fibrosis through an IGF ‐1‐induced Akt/ mTOR / HIF ‐1α pathway in keloid. The FASEB Journal. 2023;37(7). doi:10.1096/fj.202300153rr

BibTeX
@article{Guo2023,
  author = {Guo, Chipeng and Liang, Lizhu and Zheng, Jingbin and Xie, Yang and Qiu, Xiaonan and Tan, Guozhen and Huang, Jingang and Wang, Liangchun},
  title = {UCHL1 aggravates skin fibrosis through an IGF ‐1‐induced Akt/ mTOR / HIF ‐1α pathway in keloid},
  journal = {The FASEB Journal},
  year = {2023},
  volume = {37},
  number = {7},
  doi = {10.1096/fj.202300153rr}
}
Kostenlos starten →